Faulty regulation of IRF4 expression is associated with numerous lymphoid malignancies, including multiple myeloma (MM), an aggressive and incurable hematologic cancer characterized by the abnormal proliferation of bone marrow plasma cells.2, 3. Here, IRF4 is linked to Miyoshi myopathy.